BPC-157 / TB-500 Blend

Dual Peptide Research Blend | Complementary Signalling Mechanisms

This research blend combines BPC-157 (5mg) and TB-500 (5mg) in a single lyophilised vial, enabling researchers to study the combined profile of two peptides with distinct but potentially complementary mechanisms of action.

BPC-157 primarily interacts with nitric oxide and VEGFR2 signalling pathways, while TB-500 operates via actin-binding and cytoskeletal reorganisation. The two peptides represent different mechanistic entry points for studying cellular repair signalling — BPC-157 through vascular and connective tissue pathways, TB-500 through structural and migratory cellular processes.

While no peer-reviewed studies to date have examined the combination in a single controlled experiment, the overlapping areas of research interest — fibroblast activity, angiogenesis, inflammatory modulation — make this blend a practical formulation for exploratory laboratory work. Each component is individually well-characterised in the published literature.

Supplied as lyophilised powder. Each vial contains BPC-157 5mg + TB-500 5mg. Purity ≥99% by HPLC. Third-party Certificate of Analysis available — tested by Janoshik Analytical (Prague) and issued in Longev Peptides' name.

For research use only. Not for human consumption.